Statins for stroke: The second story?

Circulation

Volumn 103, Issue 3, 2001, Pages 348-350

  Plutzky, Jorge ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cholesterol; Editorials; Heart diseases; Lipids; Statins; Stroke

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ATHEROGENESIS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; ISCHEMIC HEART DISEASE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STROKE; TREATMENT OUTCOME;

EID: 0035936545     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.3.348     Document Type: Review

References (22)

1. Historical review of research on atherosclerosis
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
6. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
7. Reduction of Stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project
8. Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) Study
9. Pravastatin therapy and the risk of stroke
10. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S)
11. An overview of trials of cholesterol lowering and risk of stroke
12. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial
13. Long-term effects of pravastatin on plasma concentration of C-reactive protein
14. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
15. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
16. C-reactive protein and other markers of inflammation in the prediction of cardiovascular events in women
17. Characterization of atherosclerotic plaques by magnetic resonance imaging
18. Recently occluded intracranial and extracranial carotid arteries: Relevance of the unstable atherosclerotic plaque
19. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
20. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
21. Peroxisome proliferator activated receptors in vascular biology and atherosclerosis: Emerging insights for evolving paradigms
22. The Nobel chronicles: Joseph Leonard Goldstein (b 1940), Michael Stuart Brown (b 1941)